NCT00972374 - Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

July 31, 2011

Conditions

Rhegmatogenous Macula-off Retinal Detachment

Interventions

DRUG

400 ug Brimonidine Implant

400 ug Brimonidine Tartrate Posterior Segment Drug Delivery system on Day 1 in the study eye.

DRUG

200 ug Brimonidine Implant

200 ug Brimonidine Tartrate Posterior Segment Drug Delivery system on Day 1 in the study eye.

OTHER

Sham (no implant)

Sham Posterior Segment Drug Delivery system on Day 1 in the study eye.

Trial Locations (6)

Abilene

New Delhi

Tel Aviv

Makati

Seoul

London